Armistice Capital, Llc - 10%+ Owner at ReShape Lifesciences Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
RSLS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Armistice Capital, Llc since 9/17/2023

Holdings reported by Armistice Capital, Llc for ReShape Lifesciences Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7.22M $39.6M $5.48 Jun 28, 2021 Direct
Common Stock 7.22M $39.6M $5.48 Jun 28, 2021 Indirect
Common Stock, $.001 par value per share 2.41M Jun 15, 2021 Direct
Common Stock, $.001 par value per share 2.41M Jun 15, 2021 Indirect
Series A Warrants 0 Jun 28, 2021 Direct COMMON STOCK
Series A Warrants 0 Jun 28, 2021 Indirect COMMON STOCK
Series E Warrants 0 Jun 28, 2021 Direct COMMON STOCK
Series E Warrants 0 Jun 28, 2021 Indirect COMMON STOCK
Series G Warrants 0 Jun 28, 2021 Direct COMMON STOCK
Series G Warrants 0 Jun 28, 2021 Indirect COMMON STOCK
Warrant 0 Jun 28, 2021 Direct COMMON STOCK
Warrant 0 Jun 28, 2021 Indirect COMMON STOCK

Transactions reported by Armistice Capital, Llc for ReShape Lifesciences Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.